IP Library Patent Application 18598724
Patent Application
App. No. 18/598,724

SYSTEMS AND METHODS FOR TRANSPOSING CARGO NUCLEOTIDE SEQUENCES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/598,724
Abstract

The present disclosure provides systems and methods for transposing a cargo nucleotide sequence to a target nucleic acid site. These systems and methods may comprise a first double-stranded nucleic acid comprising the cargo nucleotide sequence, wherein the cargo nucleotide sequence is configured to interact with a retrotransposase, and the retrotransposase, wherein said retrotransposase is configured to transpose the cargo nucleotide sequence to the target nucleic acid site.

Claims (27)

1 .- 91 . (canceled)

92 . An engineered retrotransposase system comprising:

(a) a double-stranded nucleic acid comprising a cargo nucleotide sequence, wherein said cargo nucleotide sequence is configured to interact with a heterologous retrotransposase; and

(b) said heterologous retrotransposase, wherein:

(i) said heterologous retrotransposase is configured to transpose said cargo nucleotide sequence to a target nucleic acid locus; and

(ii) said heterologous retrotransposase comprises a sequence having at least 80% sequence identity to any one of SEQ ID NOs: 1-16, 32-41, 61, or 42-45.

93 . The engineered retrotransposase system of claim 92 , wherein said heterologous retrotransposase comprises a sequence having at least 80% sequence identity to any one of SEQ ID NOs: 1-16.

94 . The engineered retrotransposase system of claim 92 , wherein said heterologous retrotransposase comprises a sequence having at least 80% sequence identity to any one of SEQ ID NOs: 32-41 or 61.

95 . The engineered retrotransposase system of claim 92 , wherein said heterologous retrotransposase comprises a sequence having at least 80% sequence identity to any one of SEQ ID NOs: 42-44.

96 . The engineered retrotransposase system of claim 92 , wherein said heterologous retrotransposase comprises a sequence having at least 80% sequence identity to SEQ ID NO: 45.

97 . The engineered retrotransposase system of claim 92 , wherein said cargo nucleotide sequence is flanked by a 3′ untranslated region (UTR) and a 5′ untranslated region (UTR).

98 . The engineered retrotransposase system of claim 92 , wherein said engineered retrotransposase system is comprised in a cell, wherein said cell further comprises a deoxyribonucleic acid polynucleotide encoding said heterologous retrotransposase.

99 . The engineered retrotransposase system of claim 92 , wherein said heterologous retrotransposase comprises a nuclear localization sequence (NLS).

100 . The engineered retrotransposase system of claim 99 , wherein said NLS comprises a sequence having at least 80% sequence identity to a sequence of any one of SEQ ID NOs: 17-32.

101 . The engineered retrotransposase system of claim 98 , wherein said cell is a eukaryotic cell.

102 . A method for synthesizing complementary deoxyribonucleic acid (cDNA), the method comprising:

(a) providing a ribonucleic acid (RNA) template in a cell, wherein said RNA template comprises a cargo nucleotide sequence and said cell comprises a nucleic acid primer to initiate cDNA synthesis from said RNA template; and

(b) synthesizing cDNA initiated by said nucleic acid primer using said RNA template and a heterologous retrotransposase, wherein said heterologous retrotransposase comprises a sequence having at least 80% sequence identity to any one of SEQ ID NOs: 1-16, 32-41, 61, or 42-45.

103 . The method of claim 102 , wherein said heterologous retrotransposase comprises a sequence having at least 80% sequence identity to any one of SEQ ID NOs: 1-16.

104 . The method of claim 102 , wherein said heterologous retrotransposase comprises a sequence having at least 80% sequence identity to any one of SEQ ID NOs: 32-41 or 61.

105 . The method of claim 102 , wherein said heterologous retrotransposase comprises a sequence having at least 80% sequence identity to any one of SEQ ID NOs: 42-44.

106 . The method of claim 102 , wherein said heterologous retrotransposase comprises a sequence having at least 80% sequence identity to SEQ ID NO: 45.

107 . The method of claim 102 , wherein said cargo nucleotide sequence is flanked by a 3′ untranslated region (UTR) and a 5′ untranslated region (UTR).

108 . The method of claim 102 , wherein said RNA template and said heterologous retrotransposase are encoded by a deoxyribonucleic acid polynucleotide in said cell.

109 . The method of claim 102 , wherein said heterologous retrotransposase comprises a nuclear localization sequence (NLS).

110 . The method of claim 109 , wherein said NLS comprises a sequence having at least 80% sequence identity to a sequence of any one of SEQ ID NOs: 17-32.

111 . The method of claim 102 , wherein said cell is a eukaryotic cell.

Assignments (2)
CHANGE OF NAME Recorded Feb 6, 2026
From: METAGENOMI, INC.
To: METAGENOMI THERAPEUTICS, INC.
Reel/Frame 073717/0149 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2025
From: THOMAS, BRIAN C.; BROWN, CHRISTOPHER; GOLTSMAN, DANIELA S.A.; LAPERRIERE, SARAH; CASTELLE, CINDY; ALEXANDER, LISA; CHIU, MARY KAITLYN; TEMOCHE-DIAZ, MORAYMA; THOMAS, ANU
To: METAGENOMI, INC.
Reel/Frame 071734/0077 →